European Medicines Agency (EMA) The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines
Medicines | European Medicines Agency (EMA) The European Medicines Agency (EMA) facilitates development and access to medicines for countries within the European Union (EU) EMA evaluates applications for marketing authorisation submitted via the centralised procedure, monitors the safety of medicines across their lifecycle and provides information to healthcare professionals and patients
About us - European Medicines Agency (EMA) The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) It is responsible for the scientific evaluation, supervision and safety monitoring of medicines
Human regulatory: overview - European Medicines Agency (EMA) Information on the regulation of medicines for human use in the European Union (EU), with a focus on the centralised procedure The European Medicines Agency (EMA) plays a key role in this procedure
What we do - European Medicines Agency (EMA) The European Medicines Agency (EMA) fosters scientific excellence in the evaluation and supervision of medicines This benefits public and animal health in the European Union (EU)
Who we are - European Medicines Agency (EMA) The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU
Contacts at the European Medicines Agency On this page you can find several ways to contact the European Medicines Agency (EMA) depending on your need for assistance or type of request
News | European Medicines Agency (EMA) Search EMA's news announcementsBrinsupri significantly reduces and delays the occurrence of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis
Human Medicines | European Medicines Agency (EMA) The European Medicines Agency's (EMA) Human Medicines Division oversees human medicines throughout their lifecycle This includes the provision of guidance and advice during medicine development, the marketing authorisation process and the safety monitoring of medicines on the market It also works to facilitate access to and the optimal use of medicines, for the benefit of patients in the